JMI Syringes & Medical Devices (DHA:JMISMDL) EBITDA Margin %: 6.95% (As of Mar. 2025)


DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT139.30
View Full Analysis

What is JMI Syringes & Medical Devices EBITDA Margin %?

JMI Syringes & Medical Devices DHA:JMISMDL -0.43% 75 EBITDA Margin % is 6.95% as of Mar. 2025. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. JMI Syringes & Medical Devices's EBITDA for the three months ended in Mar. 2025 was BDT30 Mil. JMI Syringes & Medical Devices's Revenue for the three months ended in Mar. 2025 was BDT432 Mil. Therefore, JMI Syringes & Medical Devices's EBITDA margin for the quarter that ended in Mar. 2025 was 6.95%.


JMI Syringes & Medical Devices  (DHA:JMISMDL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


JMI Syringes & Medical Devices EBITDA Margin % Related Terms


JMI Syringes & Medical Devices EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices EBITDA Margin % Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.44 13.47 12.06 8.64 11.39

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.25 17.11 12.37 12.61 6.95

DHA:JMISMDL vs ISRG, BDX, MDLN: EBITDA Margin % Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's EBITDA Margin % falls into.


DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

JMI Syringes & Medical Devices's EBITDA Margin % for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=204.343/1793.61
=11.39 %

JMI Syringes & Medical Devices's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=29.974/431.545
=6.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 6.95% mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a EBITDA Margin % of 6.95% as of Mar. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' EBITDA Margin % too high?
JMI Syringes & Medical Devices' current EBITDA Margin % is 6.95%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. JMI Syringes & Medical Devices' value of 6.95% is 7% below this industry median. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' EBITDA Margin % compare to ISRG and BDX?
JMI Syringes & Medical Devices' EBITDA Margin % of 6.95% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. JMI Syringes & Medical Devices' value of 6.95% is 7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JMI Syringes & Medical Devices's current EBITDA Margin % of 6.95% is 7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on JMI Syringes & Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMI Syringes & Medical Devices's current EBITDA Margin % is 6.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current EBITDA Margin % of 6.95%. The current EBITDA Margin % is 6.95% and 7% below the Medical Devices & Instruments industry median of 7.48. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current EBITDA Margin % is 6.95% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT139.30
Price